| Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in … C Arsov, R Rabenalt, D Blondin, M Quentin, A Hiester, E Godehardt, ... European urology 68 (4), 713-720, 2015 | 212 | 2015 |
| Prediction of high-grade prostate cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European randomized study of screening for prostate … AR Alberts, MJ Roobol, JFM Verbeek, IG Schoots, PK Chiu, DF Osses, ... European urology 75 (2), 310-318, 2019 | 162 | 2019 |
| DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer C Haldrup, K Mundbjerg, EM Vestergaard, P Lamy, P Wild, WA Schulz, ... Journal of Clinical Oncology 31 (26), 3250-3258, 2013 | 149 | 2013 |
| Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard L Schimmöller, M Quentin, C Arsov, RS Lanzman, A Hiester, R Rabenalt, ... European radiology 23, 3185-3190, 2013 | 137 | 2013 |
| Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with … M Quentin, D Blondin, C Arsov, L Schimmöller, A Hiester, E Godehardt, ... The Journal of urology 192 (5), 1374-1379, 2014 | 121 | 2014 |
| MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy L Schimmöller, M Quentin, C Arsov, A Hiester, C Buchbender, R Rabenalt, ... European radiology 24, 2582-2589, 2014 | 111 | 2014 |
| T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx TK Hoffmann, C Arsov, K Schirlau, M Bas, U Friebe‐Hoffmann, ... International journal of cancer 118 (8), 1984-1991, 2006 | 111 | 2006 |
| Hypermethylation of the GABRE∼ miR-452∼ miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy H Kristensen, C Haldrup, S Strand, K Mundbjerg, MM Mortensen, ... Clinical Cancer Research 20 (8), 2169-2181, 2014 | 104 | 2014 |
| Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme A Heidenreich, HJ Scholz, S Rogenhofer, C Arsov, M Retz, SC Müller, ... European urology 63 (6), 977-982, 2013 | 101 | 2013 |
| Magnetic resonance imaging of the prostate at 1.5 versus 3.0 T: A prospective comparison study of image quality T Ullrich, M Quentin, C Oelers, F Dietzel, LM Sawicki, C Arsov, R Rabenalt, ... European journal of radiology 90, 192-197, 2017 | 97 | 2017 |
| Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results M Quentin, G Pentang, L Schimmöller, O Kott, A Müller-Lutz, D Blondin, ... Magnetic resonance imaging 32 (7), 880-885, 2014 | 84 | 2014 |
| Comparison of different mathematical models of diffusion-weighted prostate MR imaging M Quentin, D Blondin, J Klasen, RS Lanzman, FR Miese, C Arsov, ... Magnetic resonance imaging 30 (10), 1468-1474, 2012 | 79 | 2012 |
| MRI-guided in-bore biopsy: differences between prostate cancer detection and localization in primary and secondary biopsy settings L Schimmöller, D Blondin, C Arsov, R Rabenalt, P Albers, G Antoch, ... American Journal of Roentgenology 206 (1), 92-99, 2016 | 74 | 2016 |
| Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial C Arsov, N Becker, BA Hadaschik, M Hohenfellner, K Herkommer, ... Eur Urol 64 (6), 873-875, 2013 | 69 | 2013 |
| The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy C Arsov, N Becker, R Rabenalt, A Hiester, M Quentin, F Dietzel, G Antoch, ... Journal of cancer research and clinical oncology 141, 2061-2068, 2015 | 65 | 2015 |
| Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy L Schimmöller, M Quentin, C Arsov, A Hiester, P Kröpil, R Rabenalt, ... European journal of radiology 83 (12), 2103-2108, 2014 | 52 | 2014 |
| Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis A Vinarskaja, WA Schulz, M Ingenwerth, C Hader, C Arsov Urologic Oncology: Seminars and Original Investigations 31 (5), 622-627, 2013 | 48 | 2013 |
| Risk stratification of equivocal lesions on multiparametric magnetic resonance imaging of the prostate T Ullrich, M Quentin, C Arsov, AK Schmaltz, A Tschischka, N Laqua, ... The Journal of urology 199 (3), 691-698, 2018 | 44 | 2018 |
| Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate T Ullrich, M Quentin, AK Schmaltz, C Arsov, C Rubbert, D Blondin, ... European Radiology 28, 17-23, 2018 | 44 | 2018 |
| Phase 2 single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA/B (PRIMETEST) A Hiester, Y Che, A Lusch, O Kuß, G Niegisch, A Lorch, C Arsov, P Albers European Urology 84 (1), 25-31, 2023 | 35 | 2023 |
Priv.-Doz. Dr. Michael QuentinUniversity of DuesseldorfVerified email at uni-duesseldorf.de
